• We offer tailored partnerships to support and transform drug discovery.

    Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

  • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

    As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

  • Our OrganoReady program is made for you when you need optimized assays for investigational toxicology.

    We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon
EN

Poster: Organs-On-Chip Meets High Throughput Screening: Measuring Trans-Endothelial Electrical Resistance in an Endothelial Model


Poster Development of a 3D microphysiological placenta barrier in vitro model as a tool for drug transport studies Barrier function is an important readout in drug development, as the pathogenesis of many human diseases involves tissue barrier disruption, and it can be used to assess the toxic effects of the potential drug compounds. Barrier function can be assessed with Trans Epithelial Electrical Resistance (TEER) measurements. Standard TEER measurements, however, are of low throughput and require an artificial separating membrane, which limits drug permeability and physiological relevance.

In this poster, we present the OrganoTEER®, a device used to perform high throughput TEER measurements in the OrganoPlate® 3-lane. This OrganoPlate platform is based on a 384-microtiter plate which allows for a parallel culture of 40 perfused miniaturized tissues, without the obstruction of artificial membranes. Here, we cultured and analyzed the barrier function of a HUVEC based endothelial model in response to the toxicant staurosporine. The OrganoTEER showed to be a reliable tool in assessing toxic effects in both a time and dose-dependent manner.


Download the poster here

Cookies

May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy
Accept all
Accept selected
Decline all